ABIZX
Price
$21.58
Change
-$0.00 (-0.00%)
Updated
Jun 2 closing price
Net Assets
387.85M
JVMCX
Price
$27.29
Change
+$0.24 (+0.89%)
Updated
Jun 2 closing price
Net Assets
22.49B
Interact to see
Advertisement

ABIZX vs JVMCX

Header iconABIZX vs JVMCX Comparison
Open Charts ABIZX vs JVMCXBanner chart's image
ABIZX vs JVMCX Comparison Chart in %
View a ticker or compare two or three
VS
ABIZX vs. JVMCX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABIZX is a Buy and JVMCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMCX has more cash in the bank: 22.5B vs. ABIZX (388M). ABIZX pays higher dividends than JVMCX: ABIZX (0.48) vs JVMCX (0.00). ABIZX was incepted earlier than JVMCX: ABIZX (9 years) vs JVMCX (15 years). JVMCX (1.86) is less costly to investors than ABIZX (0.79). ABIZX is a more actively managed with annual turnover of: 93.00 vs. JVMCX (49.00). JVMCX has a lower initial minimum investment than ABIZX: JVMCX (1000) vs ABIZX (5000000). JVMCX annual gain was more profitable for investors over the last year : 5.42 vs. ABIZX (-0.95). ABIZX return over 5 years is better than : 13.66 vs. JVMCX (-1.33).
ABIZXJVMCXABIZX / JVMCX
Total Expense Ratio0.761.8541%
Annual Report Gross Expense Ratio0.791.8642%
Fund Existence9 years15 years-
Gain YTD-0.4615.747-8%
Front LoadN/AN/A-
Min. Initial Investment50000001000500,000%
Min. Initial Investment IRAN/AN/A-
Net Assets388M22.5B2%
Annual Yield % from dividends0.480.00-
Returns for 1 year-0.955.42-18%
Returns for 3 years19.1814.98128%
Returns for 5 years13.66-1.33-1,024%
Returns for 10 yearsN/A39.24-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PANL7.900.26
+3.40%
Pangaea Logistics Solutions Ltd
HTHT44.33-0.05
-0.10%
H World Group Limited
AARD3.97-0.02
-0.50%
Aardvark Therapeutics Inc
NIVF0.93-0.02
-2.38%
NewGenIvf Group Limited
TARS57.38-1.55
-2.63%
Tarsus Pharmaceuticals